| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 09/04/2008 | US20080213167 administering an anti-CD23 antibody and chlorambucil; B cell chronic lymphocytic leukemia |
| 09/04/2008 | US20080213166 Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas |
| 09/04/2008 | US20080213165 Caffeine, partial A2A receptor agonist; caffeine consumption prior to pharmacologic stress testing with an A2A adenosine receptor agonist abbreviate the duration of coronary vasodilation caused by the drug. |
| 09/04/2008 | CA2679514A1 18f fluoro-benzoyl labelled biologically active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy-benzoyl and trimethylammonio-benzoyl precursers |
| 09/03/2008 | EP1963291A1 Pet radiotracers |
| 09/03/2008 | EP1962913A2 Radioimmunoconjugate for human cd66 for the treatment of multiple myeloma |
| 09/03/2008 | EP1962911A2 Novel imaging agents for fibrosis |
| 09/03/2008 | EP1962868A2 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
| 09/03/2008 | EP0930844B1 Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent |
| 09/03/2008 | EP0758252B1 TIN-117m-CONTAINING RADIOTHERAPEUTIC AGENTS |
| 09/03/2008 | CN101258166A Antibody combining with STEAP-1 protein and deriving molecule thereof |
| 09/03/2008 | CN101257929A Gentisic acid for stabilisig 123-i radiopharmaceuticals |
| 09/03/2008 | CN101257916A 黑皮质素受体配体 Melanocortin receptor ligands |
| 09/03/2008 | CN101254303A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 09/03/2008 | CN101254302A Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 09/03/2008 | CN100415772C Anti-ErbB2 antibodies |
| 09/02/2008 | US7420030 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 09/02/2008 | US7419794 Antibodies specific for CYP1B1 |
| 09/02/2008 | US7419792 Detecting binding of said antigen in tissue sample; treating cells to aid in differentiation, treatment and diagnostic imaging |
| 09/02/2008 | US7419653 Method for preparing radiolabeled thymidine having low chromophoric byproducts |
| 09/02/2008 | CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 08/28/2008 | WO2008101305A1 Method for the elution of 18f fluoride trapped on an anion-exchange phase in a form suitable for efficient radiolabeling without any evaporation step |
| 08/28/2008 | WO2008063749A3 Weakly basic 2- nitroimidazoles for the non-invasive detection of tissue hypoxia |
| 08/28/2008 | US20080206148 Imaging and destruction of malignant tumors using immunoimaging agents comprising nanoclusters incorporating monoclonal antibodies that selectively bind to the cell membrane of tumor cells; conjugates include an encapsulated near-infrared (NIR) fluorescing crystal; tissue-targeted treatment |
| 08/28/2008 | US20080206138 For example, 18F-etomidate (18F-FETO); adrenal scintigraphy and diagnosis of associated disease; radionuclide therapy of adrenocortical or extraadrenal cancer |
| 08/28/2008 | US20080206137 11C-Labeled Benzyl-Lactam Compounds and Their Use as Imaging Agents |
| 08/28/2008 | US20080206136 Binding Peptidomimetics and Uses of the Same |
| 08/28/2008 | US20080206135 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 08/28/2008 | US20080206134 Radio-opaque hemostatic agents and devices and methods for the delivery thereof |
| 08/28/2008 | US20080206133 Patient-specific anticancer monoclonal antibodies for staging and diagnosis of a cancer, treating tumors and metastases; monoclonal antibody produced by hybridoma; conjugates with cytotoxic agents for tissue-targeted therapy |
| 08/28/2008 | US20080206132 Cancerous Disease Modifying Antibodies |
| 08/28/2008 | US20080206131 Compositions and Method for Multimodal Imaging |
| 08/28/2008 | US20080206130 In vivo panning for ligands to radiation-induced molecules |
| 08/27/2008 | EP1240355B1 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 08/27/2008 | EP1028754B1 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells |
| 08/27/2008 | CN101252954A Hydrazide conjugates as imaging agents |
| 08/27/2008 | CN101250201A Technetium-99m marked triazole diphosphonic acid complex and preparation method thereof |
| 08/26/2008 | CA2208981C Novel trienoic retinoid compounds and methods |
| 08/21/2008 | WO2008101234A2 Anti ganglioside gd3 antibodies and uses thereof |
| 08/21/2008 | WO2008100848A2 Novel agent for in vivo pet imaging of tumor proliferation |
| 08/21/2008 | WO2008099800A1 Method for production of radiation diagnostic imaging agent |
| 08/21/2008 | WO2008082657A3 Mri imageable liposomes for the evaluation of treatment efficacy, thermal distribution. and demonstration of dose painting |
| 08/21/2008 | WO2008028000A3 Radioimaging moieties coupled to peptidase-binding moieties for imaging tissues and organs that express peptidases |
| 08/21/2008 | US20080199439 Displaces inhibitor of apoptosis proteins (IAP) from caspase; modification of light emission when bound to cell; selectively damages or kills neoplastic cells |
| 08/21/2008 | US20080199397 Use of a Tetrapeptide Acsdkp Analogue Resistant to the Angiotensin i Conversion Enzyme, for Measuring Glomerular Filtration Rate in a Human or an Animal and Kit Containing Same |
| 08/21/2008 | US20080199396 Radioisotope Labelled Biological Compositions, And Their Use In Accelerator Mass Spectrometry |
| 08/21/2008 | US20080199370 heating radioisotope and labeling reagent in the reaction reservoir with an infrared heater to produce radiopharmaceuticals; reproducibly positionable with respect to an infrared source; access in a closed or semi-closed loop system; minimize evaporation loss; novel temperature control feedbacks |
| 08/21/2008 | CA2678020A1 Method for production of radiation diagnostic imaging agent |
| 08/20/2008 | EP1958954A1 Process for production of compound labeled with radioactive fluorine |
| 08/20/2008 | EP1958953A1 Process for production of compound labeled with radioactive fluorine |
| 08/20/2008 | EP1957116A2 Radiolabelling method using polymers |
| 08/20/2008 | EP1957114A2 Novel imaging agents for fibrosis |
| 08/20/2008 | EP1957059A1 Androgen-receptor (ar) ligands for use in the treatment and diagnosis of ar-related pathologies |
| 08/20/2008 | EP1743174A4 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 08/20/2008 | EP1622602B1 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 08/20/2008 | EP1479084B1 Apparatus, method for separating carrier-free radionuclides, and the radiochemical reaction thereof |
| 08/20/2008 | EP1051206B1 A multi-formed collagenous biomaterial medical device |
| 08/20/2008 | EP1047455B1 Para-hydrogen labelled agents and their use in non-proton magnetic resonance imaging |
| 08/20/2008 | EP0724651B1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 08/19/2008 | US7414121 DNA sequence encoding an antibody fusion protein which is useful for the treatment and diagnosis of various cancers, including colon cancer; anticarcinogenic agents; biodrugs |
| 08/19/2008 | US7414047 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 08/19/2008 | US7413727 Contrast agents |
| 08/14/2008 | WO2008098112A2 Positron emission tomography imaging method |
| 08/14/2008 | WO2008096905A1 Anti-brak (cxcl14) human monoclonal antibody and use thereof |
| 08/14/2008 | WO2008096760A1 NOVEL HEXATRIENE-β-CARBONYL COMPOUND |
| 08/14/2008 | US20080193460 or immunoreactive fragment thereof that binds to the Mu-9 epitope of a colon-specific antigen-p mucin (CSAp) antigen; binds target tissue and conjugate carrying epitope (haptens)l; immunoconjugate; fusion proteins; colon cancer |
| 08/14/2008 | US20080193451 Chimeric, Human and Humanized Anti-CSAP Monoclonal Antibodies |
| 08/14/2008 | US20080193380 Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy |
| 08/14/2008 | US20080193379 Radioactive Diagnostic Imaging Agent |
| 08/14/2008 | US20080193378 Radio Metal Complexes Based on Bispidine and the Derivatives Thereof as Chelating Agents, and Use Thereof for Nuclear Medical Diagnosis and Therapy |
| 08/14/2008 | US20080193377 treating solid tumors with drug-polymeric conjugates, that specifically target endothelial cells supporting tumor angiogenesis; tissue-targeted therapy; radiotherapy |
| 08/14/2008 | US20080193376 Methods of Enhanced Detection and Therapy of Inflamed Tissues Using Immune Modulation |
| 08/14/2008 | US20080193375 Lung cancer-targeted peptides and applications thereof |
| 08/14/2008 | US20080193374 a solution comprising alpha ray emitters and chemotherapeutic agents, encapsulated in lipids, used as anticarcinogenic agents |
| 08/14/2008 | US20080193373 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| 08/14/2008 | US20080193372 Efficacy and Safety of Targeted Particulate Agents with Decoy Systems |
| 08/14/2008 | CA2678194A1 Anti-human brak (cxcl14) monoclonal antibody and use thereof |
| 08/14/2008 | CA2677792A1 Positron emission tomography imaging method |
| 08/13/2008 | EP1956374A1 Detection and treatment of cancer |
| 08/13/2008 | EP1956013A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 08/13/2008 | EP1954720A1 Antibodies and immunotoxins that target human glycoprotein nmb |
| 08/13/2008 | EP1954322A2 Mitochondria-targeted antioxidant prodrugs and methods of use |
| 08/13/2008 | EP1954259A2 Amidine derivatives for in vivo imaging |
| 08/13/2008 | EP1791571B1 Radiofluorinated peptides |
| 08/13/2008 | EP1483290B1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 08/13/2008 | EP0647137B1 Glycine receptor antagonists and the use thereof |
| 08/13/2008 | CN101239190A Vitamin receptor binding drug delivery conjugates |
| 08/13/2008 | CN101239012A Method for acquiring maxilla coloboma section model |
| 08/13/2008 | CN100409898C Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody |
| 08/12/2008 | US7411041 DCRS5 polypeptides |
| 08/12/2008 | US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 08/12/2008 | US7410665 Controlled release of peptide active materials; vapor deposition |
| 08/12/2008 | US7410639 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |
| 08/12/2008 | CA2252399C Composition for demonstrating the presence of ammonia in exhaled air |
| 08/07/2008 | WO2008093881A1 Method for synthesis of nitroxyl radical |
| 08/07/2008 | WO2008074804A3 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |
| 08/07/2008 | US20080187493 Peptide-Based Compounds |
| 08/07/2008 | US20080187489 Generator and Method for Production of Technetium-99m |
| 08/07/2008 | US20080187488 Phage antibodies to radiation-inducible neoantigens |
| 08/07/2008 | US20080187487 Methods for producing multilayered particles, fibers and sprays and methods for administering the same |